Open AccessAdjuvant chemotherapy for gastric cancer in elderly patients has same benefits as in younger patients
Author(s) -
Mustafa Karaca,
Deniz Tural,
Hakan Koçoğlu,
Fatıh Selcukbiricik,
İrem Bilgetekin,
Ahmet Özet
Publication year - 2018
Publication title -
journal of cancer research and therapeutics/journal of cancer research and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.475
H-Index - 39
eISSN - 0973-1482
pISSN - 1998-4138
DOI - 10.4103/0973-1482.172588
Subject(s) - medicine , cancer , lymphovascular invasion , perineural invasion , chemotherapy , stage (stratigraphy) , gastroenterology , surgery , metastasis , paleontology , biology
The age-adjusted mortality rate due to gastric cancer was reported to increase with age. This study aims to investigate the results of adjuvant chemotherapy in patients aged 65 years or older comparing with younger patients and focusing on its impact on survival.